Proprietary diagnostic and medical device technologies developer and investment partner Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) announced…
Read More »Press Releases
Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a developer and investment partner in cutting-edge diagnostic and medical device technologies,…
Read More »
Therma Bright (TSXV: THRM) (OTCQB: TBRIF), a developer and investment partner in advanced diagnostic and medical device technologies, announced the…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Jordan R. Plews, PhD has…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, reported its financial results for the first quarter ended March…
Read More »
ELEVAI Labs established two subsidiaries: ELEVAI Biosciences, Inc., and ELEVAI Skincare, Inc. ELEVAI Biosciences will focus on acquiring and developing…
Read More »
The company’s international distribution agreements have a contracted cumulative minimum purchase requirement of up to $4.9 million over the first…
Read More »
The Asia-Pacific market represents a $13 billion prestige skincare and luxury haircare market opportunity, with the Taiwan deal giving the…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced certain preliminary, unaudited management-prepared financial results for…
Read More »